Tukysa Den Europæiske Union - dansk - EMA (European Medicines Agency)

tukysa

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiske midler - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Copiktra Den Europæiske Union - dansk - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Ketoconazole HRA Den Europæiske Union - dansk - EMA (European Medicines Agency)

ketoconazole hra

hra pharma rare diseases - ketoconazol - cushing syndrome - antimykotika til systemisk brug - ketoconazol hra er indiceret til behandling af endogent cushings syndrom hos voksne og unge over 12 år.

Curosurf 80 mg/ml endotracheopulmonal instillationsvæske, suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

curosurf 80 mg/ml endotracheopulmonal instillationsvæske, suspension

chiesi farmaceutici s.p.a. - phospholipidfraktion fra griselunge - endotracheopulmonal instillationsvæske, suspension - 80 mg/ml